Japan suspends 1.6 million vaccine doses due to 'tainted vials'
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Japan is suspending the use of more than one-and-a-half million COVID-19 vaccine doses due to contamination concerns.
Japanese authorities said Thursday they're halting the use of more than 1.6 million doses of the Moderna coronavirus vaccine "after some vaccination sites reported finding tainted vials," The New York Times writes. According to the Times, contaminants were found in almost 40 doses at eight locations in Japan.
"Moderna confirms having been notified of cases of particulate matter being seen in drug product vials of its COVID-19 vaccine," Moderna said. "...Moderna believes the manufacturing issue was generated in one of the lines used at its contract manufacturing site in Spain. Out of an abundance of caution, Moderna has put this lot and two adjacent lots on hold."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This comes as Japan, which had a slow start to its vaccine rollout, has been experiencing a surge in COVID-19 cases amid the spread of the Delta variant. According to The Association Press, about 43 percent of Japan's population has been fully vaccinated. Despite this vaccine setback, Chief Cabinet Secretary Katsunobu Kato said that officials will "do utmost in order to avoid any impact on vaccination progress." Kato also said that "we have not received reports of health problems" due to the reported contamination but that "we are asking people to consult their physicians if they experience any abnormality."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
The environmental cost of GLP-1sThe explainer Producing the drugs is a dirty process
-
Greenland’s capital becomes ground zero for the country’s diplomatic straitsIN THE SPOTLIGHT A flurry of new consular activity in Nuuk shows how important Greenland has become to Europeans’ anxiety about American imperialism
-
‘This is something that happens all too often’Instant Opinion Opinion, comment and editorials of the day
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
